| Blasco AJ, Lázaro P, Ferrándiz C, et al.
Efficiency of Biologic Agents in the Treatment of Moderate to Severe Psoriasis. [JOURNAL ARTICLE]
Actas Dermosifiliogr 2009 Nov; 100(9):792-803.
Abstract | Full Citation | Find Related Articles |
| Alivernini S, Laria A, Gremese E, et al.
ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature. [JOURNAL ARTICLE]
Arthritis Res Ther 2009 Nov 3; 11(6):R163.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Gisbert JP
Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding. [JOURNAL ARTICLE]
Inflamm Bowel Dis 2009 Nov 2.
Abstract | Full Citation |
| Singh JA, Christensen R, Wells GA, et al.
A network meta-analysis of randomized controlled trials of biologics for rheumatoid arthritis: a Cochrane overview. [JOURNAL ARTICLE]
CMAJ 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Cuéllar MJ, Marco JL, Pérez-Castelló I, et al.
[Quality of storage of thermolabile drugs in patients' homes.] [JOURNAL ARTICLE]
Rev Calid Asist 2009 Oct 31.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Wetter DA, Davis MD
Lupus-like syndrome attributable to anti-tumor necrosis factor alpha therapy in 14 patients during an 8-year period at Mayo Clinic. [Journal Article]
Mayo Clin Proc 2009 Nov; 84(11):979-84.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Askling J, van Vollenhoven RF, Granath F, et al.
Cancer risk in patients with rheumatoid arthritis treated with anti-tumor necrosis factor alpha therapies: Does the risk change with the time since start of treatment? [JOURNAL ARTICLE]
Arthritis Rheum 2009 Oct 29; 60(11):3180-3189.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |
| Emmert MY, Salzberg SP, Emmert LS, et al.
Severe cardiomyopathy following treatment with the tumour necrosis factor-alpha inhibitor adalimumab for Crohn's disease. [Journal Article]
Eur J Heart Fail 2009 Nov; 11(11):1106-9.
Abstract | Full Citation |
| Marchesoni A, Altomare G, Matucci-Cerinic M, et al.
An Italian shared dermatological and rheumatological proposal for the use of biological agents in psoriatic disease. [JOURNAL ARTICLE]
J Eur Acad Dermatol Venereol 2009 Oct 23.
Abstract | Full Citation |
| Pink AE, Fonia A, Allen MH, et al.
Antinuclear antibodies associate with loss of response to anti-TNF alpha therapy in psoriasis - a retrospective, observational study. [JOURNAL ARTICLE]
Br J Dermatol 2009 Oct 26.
Abstract | Full Citation | Find Related Articles |
  |
